TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget October 1, 1982
TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997
